|
|
|
SOUTH AFRICA: Possible anti-AIDS generic go-ahead for drug firms
[This report does not necessarily reflect the views of the United Nations]
JOHANNESBURG, 26 January (PLUSNEWS) - Pharmaceutical giant Merck Sharp and Dohme (MSD) could soon allow generic manufacturers in South Africa to produce its patented anti-AIDS drugs reported a local newspaper, the Cape Argus.
The decision follows a recent fracas between the AIDS activist group, Treatment Action Campaign (TAC), and MSD over a shortage of efavirenz, a drug used to treat HIV infection in children older than three.
Although neither party was willing to divulge details of any plans for a generic equivalent to be produced locally, MSD chief executive Chirfi Guindo said the company and TAC were "in discussions with potential candidates" to manufacture the medication.
A joint statement by TAC and MSD is expected in the next few weeks.
[ENDS]
:: MORE NEWS BRIEFS ::
|
|
|
|
|
|
|
| Links |
· AIDS Media Center
|
· The Global Fund to fight AIDS, Tuberculosis & Malaria
|
· International Community of Women Living with HIV/AIDS
|
· AEGIS
|
· International HIV/AIDS Alliance
|
PlusNews does not take responsibility for info in links supplied.
|
|
|
|
|
[Back] [Home Page]
Click here to send any feedback, comments or questions you have about PlusNews Website or if you prefer you can send an Email to Webmaster
Copyright © IRIN 2006
The material contained on www.PlusNews.org comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN Office for the Coordination of Humanitarian Affairs.
|
